CTLA4 and colorectal carcinoma: In addition, the immunophenoscore (IPS) for predicting anti-PD1 and anti-CTLA4 therapeutics among TCGA CRC patients was obtained from the Cancer Immunome Atlas (TCIA, https://tcia.at/home).